Zoonotic Diseases Quick Review

Pandemics and Disease

  • Pandemics have occurred throughout history, influenced by trade, urbanization, and disease virulence.
  • Quarantine originated in the 14th century to protect cities from plague.
  • Dr. John Snow used geographical data to link a cholera outbreak to tainted water in 19th century London.
  • Modern responses to pandemics are improving due to better understanding of disease.
  • Urbanization and increased air travel significantly impact infectious disease spread.

Major Pandemics in History

  • Antonine Plague (165-180): Believed to be smallpox or measles, 5M deaths.
  • Plague of Justinian (541-542): Yersinia pestis, 30-50M deaths.
  • Black Death (1347-1351): Yersinia pestis, 200M deaths.
  • Spanish Flu (1918-1919): H1N1 virus, 40-50M deaths.
  • HIV/AIDS (1981-present): Virus, 25-35M deaths.
  • COVID-19 (2019-Present): Coronavirus, 5.7M+ deaths.

Zoonotic Diseases

  • Zoonotic diseases transmit from vertebrate animals to humans and vice versa; >60% of human pathogens are zoonotic.
  • Factors like climate change, urbanization, and trade affect zoonoses emergence and distribution.
  • The WHO defines zoonosis as any disease transmissible between vertebrate animals and humans.
  • Zoonoses are a public health concern, causing significant illness and death, mainly impacting livestock workers in low-income countries.
  • Zoonoses are classified into bacterial, viral, parasitic, fungal, rickettsial, chlamydial, and protozoal types.
  • Transmission can be direct (e.g., avian influenza) or via vectors (e.g., rabies from animal bites).
  • Zoonotic diseases are classified into synanthropic and exoanthropic based on their ecosystem.
  • Sapronoses: diseases caused by pathogens surviving on dead organic material (fungal and bacterial).
  • Reverse zoonoses: diseases transmitted from humans to animals.

Zoonoses of Domestic Animals

  • Domestic animals are significant in transmitting diseases to humans.
  • Transmission occurs through direct contact, ingestion, or inhalation.
  • Examples: Anthrax (Bacillus anthracis), Tuberculosis (Mycobacterium bovis), Brucellosis (Brucella spp.), Rabies (Rabies virus).
  • Anthrax: transmitted through contact with infected animals/products; mortality can reach 100% in pulmonary form.
  • Tuberculosis: transmitted via unpasteurized milk/aerosols; can affect the urogenital system.
  • Brucellosis: transmitted via unpasteurized milk/products; causes flu-like symptoms.
  • Rabies: transmitted by animal bites; causes excitation, hallucination, and hydrophobia.

Zoonoses of Pets, Companion Animals, and Birds

  • Close contact with pets increases zoonoses risk.
  • Common diseases: Brucellosis, Campylobacteriosis, Chlamydiosis, Cat scratch fever, Rabies, Lyme disease, Tularemia.
  • Birds can transmit Coxiella burnetii, Salmonella spp., and avian influenza A H5N1.
  • Transmission occurs through direct or indirect contact.
  • Cat-scratch disease: caused by Bartonella henselae, transmitted through cat scratches/bites.

Zoonoses of Fish and Aquatic Environments

  • Fish can harbor zoonotic pathogens, mainly bacteria.
  • Pathogens originate from the aquatic environment contaminated by human and animal waste.
  • Transmission occurs through non-hygienic handling or consumption of raw/undercooked products.
  • Important pathogens: Aeromonas hydrophila, E. coli, Vibrio spp., Mycobacterium marinum, Erysipelothrix rhusiopathiae, Lactococcus garvieae, Nocardia spp.
  • Mycobacterium marinum causes "fish tank granuloma."
  • Erysipelothrix rhusiopathiae causes "fish-handler’s disease."
  • Lactococcus garvieae causes endocarditis, bacteremia, and meningitis.
  • Nocardia spp. causes nocardiosis, characterized by skin infections and pneumonia.

Zoonoses Associated with Food-Borne Pathogens

  • Food acts as a medium to transmit zoonotic pathogens; causes diarrheal diseases.
  • Risk factors: Handling animals without precautions, consuming undercooked animal products.
  • Common pathogens: Salmonella spp., Campylobacter spp., Shiga toxin-producing Escherichia coli (STEC), and hepatitis E virus.
  • STEC toxins cause gastrointestinal symptoms and kidney failure; can induce hemolytic uremic syndrome (HUS).

Potential Zoonoses Transmitted by Edible Insects

  • Edible insects (beetles, caterpillars, ants) increasingly consumed globally.
  • Health risks: allergies, metabolic steroids, pathogens, and parasites.
  • Insects can harbor pathogens like Campylobacter spp., Enterobacteriaceae, and act as vectors for Salmonella spp. and E. coli.

Emerging and Re-Emerging Zoonoses

  • Emerging zoonosis: newly recognized or increased incidence.
  • Factors: human behavior, habitat, ecology, farm practices, urbanization, deforestation, and climate change.
  • Examples: Avian influenza, Ebola, MERS, SARS, COVID-19.
  • SFTS: severe fever with thrombocytopenia syndrome, transmitted by ticks.
  • MERS: transmitted to humans from camels.

Wild Animals and Re-Emerging Zoonoses

  • Wild animals are intricately connected with human/domesticated animals, and environmental components.
  • Globalization, habitat destruction, climatic change, and loss of species and biodiversity disrupts the ecological relations.
  • Wild animals: reservoirs of pathogens that threaten human/animal health, agriculture, and wildlife.

Zoonotic Coronaviruses

  • Coronaviruses: enveloped, positive-sense single-stranded RNA viruses.
  • All seven human coronaviruses are zoonotic, with bats as natural hosts.
  • SARS-CoV, MERS-CoV, and SARS-CoV-2 (COVID-19) are the most severe.
  • Transmission occurs through respiratory droplets and fomites.

Neglected Zoonoses

  • Endemic in the developing world, often under-reported and neglected.
  • Examples: Rabies, Anthrax, Cysticercosis, Brucellosis, Leishmaniasis.

Impact of Zoonoses

  • Impacted by prevalence, incidence, morbidity, mortality, and economic loss.
  • Antibiotic resistance: global health challenge that negatively impacts the treatment of bacterial zoonoses.
  • Animal deaths or reduced productivity result in massive economic losses.
  • Various disease hampers with international trade and tourism.

Control of Zoonoses

  • Requires multi-sectorial approach involving humans, animals, and the environment.
  • Surveillance can be used to detect early infection; improve human health status, manage disease properly, and minimize morbidity and mortality of humans and animals.
  • Types of surveillance: Pathogen serological syndrome and risk.
  • General principals of disease control provides a treatment to a_ected individuals, can vaccination of healthy individuals and animals, restricting animal movement, animal population control, and test and cull
  • Requires combined and multidisciplinary approaches with e_ective epidemiological, vectrol, vector control, and risk management
  • Preventable through hygiene awareness vaccination, and medical checkup.
  • Developed countries aid in supporting the controlling of Zoonoses.

Agent Details: Plague (Yersinia pestis)

  • Plague is a devastating epidemic disease known from ancient times.
  • Three global pandemics: Justinian Plague, Black Death, and the last started in China in the 1860s.
  • Yersinia pestis discovered by A. Yersin in 1894.
  • Morphology: Small gram-negative rods with bipolar stain ("closed safety pins"), nonmotile, has capsule.
  • Cultivation: Grows on ordinary nutrient media; optimal temperature: 25-30°C, R-form colonies.
  • Virulence factors: 72-kb virulence plasmid (pYV), Yop proteins, K-antigen, plasminogen activator, lipopolysaccharide; the structure of lipid part of endotoxin alters in order to stimulates bacteria against phagocytosis
  • Epidemiology: Zoonotic disease of rodents transmitted to humans via fleabites.
  • Clinical findings: bubonic, pneumonic, or septicemic forms; may also have cutaneous and intestinal forms; fever with extremely painful bubo.
  • Laboratory diagnosis: Specimens from blood, sputum, or lymph node aspirates.
  • Treatment and prophylaxis: Aminoglycoside antibiotics (streptomycin or gentamycin); live EV vaccine and formaldehyde-inactivated vaccine, effectiveness of vaccination is generally moderate.

Agent Details: Anthrax (Bacillus anthracis)

  • Bacterial origin noted by A. Pollander, K. Davaine, and F. Brauell; first isolated by R. Koch in 1876.
  • Bacillus genus: soil, water, air, and vegetation; B. anthracis is the principal pathogen.
  • Morphology: Large gram-positive rods, nonmotile, encapsulated, and arranged in chains (streptobacilli).
  • Cultivation: Grows well in ordinary media and sheep blood agar at 37°C; colonies resemble the "head of a medusa."
  • Virulence factors: Exotoxins (PA, EF, LF) and antiphagocytic polypeptide capsule.
  • Resistance: Spores survive in soil for decades; animal carcasses are highly infectious. As the environmental conditions play a substantial role in preservation and spread of anthrax germs, the infection caused by B. anthracis is referred to as sapronosis.
  • Epidemiology: Herbivores become infected with anthrax by grazing in pastures; potential source of infection is a vast number of wild and domestic animals.
  • Clinical findings: Cutaneous, inhalation (Wool-sorter´s disease), or gastrointestinal forms, fever with tachypnea.
  • Laboratory diagnosis: B. anthracis may be isolated from various samples: cutaneous lesions, respiratory specimens, stool or other gastrointestinal excretions, blood or cerebrospinal fluid.
  • Treatment and prophylaxis: live (attenuated) vaccine containing spores of non-capsulated B. anthracis vaccine strain and aluminum hydroxide-precipitated protective antigen is used

Agent Details: Brucellosis (Brucellae)

  • Established by B. Bang in 1896 as contagious abortion of cattle.
  • Types: B. melitensis (goats/sheep), B. abortus (cattle), B. suis (pigs); predominantly associated with associated with human patholody
  • Morphology: Small gram-negative ovoid-shaped coccobacteria, no spores or capsules (except capsulated B. melitensis).
  • Cultivation: Slow growth; special media (liver-extract agar and liver-extract broth) with the optimal temperature of culture is 37°C
  • Antigenic structure: Brucella melitensis carries predominantly M fraction, whereas Brucella abortus group – A fraction.
  • Virulence factors: Virulence factors of brucellae remain not well-determined and genome doesn’t harbor genetic pathogenicity islands
  • Transmission: direct or indirect contact with infected animals as result of contact with infected tissues of animals, via cutaneous, respiratory, or alimentary routes
  • Clinical findings: The is no specific symptoms, affects tissues, and the onset of illness may be acute or insidious
  • Laboratory diagnosis: Specimens from patient’s blood and urine (for isolation of the pathogen), serum (for detection of antibodies), milk and dairy products (for detection of brucellae) are examined
  • Treatment and prophylaxis: various live and inactivated vaccines were introduced into clinical practice

Agent Details: Tularemia (Francisella tularensis)

  • Causative agent first described by G. McCoy and Ch. Chapin in Californian town Tulare in 1912
  • Types: F. tularensis subsp. tularensis (type A) and F. tularensis subsp. holarctica (type B)
  • Morphology: Small pleomorphic gram-negative coccobacterium, no spores or capsule.
  • Cultivation: Doesn´t grow on ordinary media, special media is cultured on glucose blood agar, chocolate agar or charcoal yeast extract agar, 37°C Small, smooth, gray-white, flat, and shiny colonies is giving after 48 h of incubation
  • Antigenic structure: contains superficial capsule-like Vi and somatic lipopolysaccharide O antigen for the two major biogroups of Francisella tularensis
  • Virulence: Virulence factors are not well studied due to the bacteria can infect humans by intact skin
  • Transmission: Numerous rodent species, transmitted via direct animal contact or via insect bites
  • Clinical findings: Depend on the site of entry (cutaneous, inhalation, or ingestion) with the symptoms high fever with acute onset accompanied with chills
  • Laboratory diagnosis: Diagnostic, but francisella should be cultured only in biological safety cabinet of BSL-2 level maintaining all personal safety measures
  • Treatment and prophylaxis: the individuals of high risk (e.g., laboratory personnel) are immunized with live attenuated vaccine of F. tularensis created by N. Gaisky and B. Elbert.